Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on More

Home>Events>3rd Upstream Seminar - Switzerland
Back to previous page

3rd Upstream Seminar, Switzerland – November 29th and 30th, 2016

Solutions for modern upstream bioprocessing

You are invited!

After the success of the former upstream seminars, we are pleased to invite you to the third edition of this event. This year will include an extended scope from cell-line and media development to GMP production of large molecules and cell-based vaccines.

November 29th and 30th, 2016 3rd Upstream Seminar
Hotel Royal
Geneva, Switzerland
Register Now

This 3rd Upstream seminar "Solutions for modern upstream bioprocessing" will gather industry experts and thought leaders in upstream processing from diverse companies specialized in the development and production of biopharmaceuticals and vaccines.

During this session, you will have the opportunity to:

  • Network with peers in a friendly environment to gain insights into latest industry trends and innovations in upstream processing,
  • Learn from industry speakers who can provide critical feedback with regards to upstream process development strategies,
  • Visit our Aubonne cGMP facility to interact with users of single-use bioreactor at 2000 L scale.

Agenda Day 1

29 November 2016

Cell line and media development strategies for modern expression systems
12:00 – 1:45 pmFinger food and reception
1:45 – 2:00 pmWelcome and introduction
 Christian G Martin – Merck, Life Science
2:00 – 2:30 pmModern media development: how to deal with the process, yield and quality attributes?
 Martin Jordan – Merck, Healthcare
2:30 – 3:00 pmNovel approach to cell culture media optimization
 Elena Krendeleva – Biocad
3:00 – 3:30 pmDevelopment of advanced cell culture media technologies
 Aline Zimmer – Merck, Life Science
3:30 – 4:00 pmCoffee break and poster session
4:00 – 4:30 pmRaw materials for cell culture processes: from manufacturer to customer
 Luc Kupers – Genzyme, a Sanofi Company
4:30 – 5:00 pmNew strategies for virus risk mitigation
 David Onions – Bioreliance, a part of Merck
7:00 pmDinner at Edelweiss restaurant

Agenda Day 2

30 November 2016

Flexible and scalable solutions from process development to cGMP manufacturing
8:45 – 9:00 amIntroduction day 2
9:00 – 9:30 amFast-track lentiviral vector upstream process development
 Landry Bertaux – Sanofi Pasteur
9:30 – 10:00 amSingle-use bioreactor and r-trypsin evaluation for veterinary vaccine production
 Géraldine Popovic – Merial
10:00 – 10:30 amScaling strategy from bench to 2000 L single-use and 15000 L stainless steel bioreactors
 Nicolas Fouque – Merck, Healthcare
10:30 – 10:45 amCoffee break
10:45 – 11:15 amIntensified perfusion processes: small scale modelling and cell culture media development
 Delia Lyons – Merck, Life Science
11:15 – 12:00 pmFlexible facility needs and opportunities
 Maik Jornitz – G-Con
 Flexible facilities for flexible operations: case studies
 Sébastien Ribault – Merck, Biodevelopment
12:00 – 12:15 pmPanel discussion
12:15 – 1:15 pmLunch
1:15 pmDeparture to Merck Healthcare facility (Aubonne)
2:00 – 4:00 pmMerck Aubonne facility presentation
Flocculation in the 2000 L bioreactor: a solution for high cell density clarification
Hands-on session with Mobius® 200 L and 2000 L single-use bioreactors
5:00 pmArrival at Geneva Royal Hotel

Space is limited, register now!

Agenda subject to change. Attendance of the 3rd Upstream seminar ("Solutions for modern upstream bioprocessing") is limited and available to pharma/biopharma manufacturers and academics only. The offer does not extend to any company that provides products or services to the pharma/biopharma industries. Merck reserves the right to revoke or refuse participation at any time. Attendance is free, though registration is required. Lunch, dinner, and coffee breaks are provided courtesy of Merck. Travel costs and hotel accommodation are at the expense of the attendees.